Drug Profile
Guanabenz
Alternative Names: Guanabenz - The Myelin Repair Foundation/National Institute of Health; MRF 008Latest Information Update: 21 Oct 2021
Price :
$50
*
At a glance
- Originator Myelin Repair Foundation; National Institute of Neurological Disorders and Stroke
- Class Antihypertensives; Guanidines
- Mechanism of Action Immunostimulants; Myelin protein stimulants; Nerve growth factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Multiple sclerosis